Schedule 13G ownership disclosure
AMBRX BIOPHARMA INC
Security class unavailable · CUSIP: 02290A102
Event date: 2022-12-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 50,641,423
- Percent of class
- 18.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-22-005216
- Form type
- SC 13G
- Filer
- Ambrx Biopharma Cayman, Inc.
- CIK
- CIK 1836056
- Filed
- Dec 19, 2022
- Reporting period
- Dec 09, 2022
- Description
- Schedule 13G beneficial ownership